Managing Resistance to Anti-HIV Drugs: An Important Consideration for Effective Disease Management

Author： Vandamme M.   Van Laethem K.   De Clercq E.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.57, Iss.3, 1999-03, pp. : 337-361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging anti-HIV drugs

By De Clercq Erik  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 241-274

Informa Healthcare

Access to resources Recommend Favorite

Assault on Resistance: The Use of Computational Chemistry in the Development of Anti-HIV Drugs

By  

Current Pharmaceutical Design, Vol. 12, Iss. 15, 2006-05 ,pp. : 1843-1856

Bentham Science Publishers

Access to resources Recommend Favorite

Action of Anti-HIV Drugs and Resistance: Reverse Transcriptase Inhibitors and Protease Inhibitors

By  

Current Pharmaceutical Design, Vol. 10, Iss. 32, 2004-12 ,pp. : 4039-4053

Bentham Science Publishers

Access to resources Recommend Favorite

Combinations Against Combinations: Associations of Anti-HIV 1 Reverse Transcriptase Drugs Challenged by Constellations of Drug Resistance Mutations

By  

Current Drug Metabolism, Vol. 3, Iss. 1, 2002-02 ,pp. : 73-95

Bentham Science Publishers

Access to resources Recommend Favorite

Trends in the Design of Nucleoside Analogues as Anti-HIV Drugs

By  

Current Pharmaceutical Design, Vol. 8, Iss. 8, 2002-04 ,pp. : 581-593

Bentham Science Publishers

Access to resources Recommend Favorite